129 related articles for article (PubMed ID: 1356350)
1. Current status of therapy for human immunodeficiency virus type 1.
Lane HC
Curr Opin Immunol; 1992 Aug; 4(4):486-9. PubMed ID: 1356350
[TBL] [Abstract][Full Text] [Related]
2. Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group.
Schooley RT; Ramirez-Ronda C; Lange JM; Cooper DA; Lavelle J; Lefkowitz L; Moore M; Larder BA; St Clair M; Mulder JW; McKinnis R; Pennington KN; Harrigan PR; Kinghorn I; Steel H; Rooney JF
J Infect Dis; 1996 Jun; 173(6):1354-66. PubMed ID: 8648207
[TBL] [Abstract][Full Text] [Related]
3. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.
Abrams DI; Goldman AI; Launer C; Korvick JA; Neaton JD; Crane LR; Grodesky M; Wakefield S; Muth K; Kornegay S
N Engl J Med; 1994 Mar; 330(10):657-62. PubMed ID: 7906384
[TBL] [Abstract][Full Text] [Related]
4. Treatment of HIV infection: the antiretroviral nucleoside analogues. Introduction.
McLeod GX; Hammer SM
Hosp Pract (Off Ed); 1992 Aug; 27 Suppl 2():3-4. PubMed ID: 1324256
[No Abstract] [Full Text] [Related]
5. Current perspectives on antiretroviral therapy.
Fletcher CV
Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
[TBL] [Abstract][Full Text] [Related]
6. Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future.
Yarchoan R; Pluda JM; Perno CF; Mitsuya H; Broder S
Blood; 1991 Aug; 78(4):859-84. PubMed ID: 1714326
[No Abstract] [Full Text] [Related]
7. Therapy for human immunodeficiency virus infection -- what have we learned?
Corey L; Holmes KK
N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046
[No Abstract] [Full Text] [Related]
8. Therapy for human immunodeficiency virus infection.
Hirsch MS; D'Aquila RT
N Engl J Med; 1993 Jun; 328(23):1686-95. PubMed ID: 8387640
[No Abstract] [Full Text] [Related]
9. HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating Committee.
Brun-Vézinet F; Boucher C; Loveday C; Descamps D; Fauveau V; Izopet J; Jeffries D; Kaye S; Krzyanowski C; Nunn A; Schuurman R; Seigneurin JM; Tamalet C; Tedder R; Weber J; Weverling GJ
Lancet; 1997 Oct; 350(9083):983-90. PubMed ID: 9329513
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy in HIV-infected adults. Which regimens are recommended?
Lancaster DJ; Lancaster LL
Postgrad Med; 1994 Jan; 95(1):47-50, 53-5. PubMed ID: 7904062
[TBL] [Abstract][Full Text] [Related]
11. A trial comparing nucleoside monotherapy with sequential therapy with 3 drugs in HIV-infected patients.
Roca B; Olmos P; Mínguez C; Arnedo A; Usó J; Teruel C; Segarra M; Sáez-Royuela A; Simón E
Scand J Infect Dis; 1998; 30(4):426-8. PubMed ID: 9817530
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection.
Arendt G; von Giesen HJ; Hefter H; Theisen A
AIDS; 2001 Mar; 15(4):493-500. PubMed ID: 11242146
[TBL] [Abstract][Full Text] [Related]
13. The use of nucleoside analogues in the treatment of HIV-infected children.
Husson RN; Pizzo PA
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1059-64. PubMed ID: 1323984
[No Abstract] [Full Text] [Related]
14. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
15. [Anti-HIV therapy (1987-1994): from nothing to confusion].
Lissen E
Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
[No Abstract] [Full Text] [Related]
16. Antiretroviral therapy of human immunodeficiency virus type-1 (HIV-1) infection.
Emery S; Cooper DA
Aust N Z J Med; 1995 Aug; 25(4):344-9. PubMed ID: 8540876
[No Abstract] [Full Text] [Related]
17. [Weak antiviral effect of changing two nucleoside analogues combined with antiretroviral agents. 3TC and d4T after ZDU and ddi or ddc].
Rey D; Schmitt AC; Schmitt MP; Partisani M; Nicolle M; Kempf-Durepaire G; Krantz V; Lang JM
Presse Med; 1998 Feb; 27(8):360. PubMed ID: 9768003
[No Abstract] [Full Text] [Related]
18. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
[No Abstract] [Full Text] [Related]
19. [Anti-retroviral monotherapy with nucleoside analogues].
de Mendonça JS
Rev Soc Bras Med Trop; 1995; 28 Suppl 2():5-9. PubMed ID: 8693151
[No Abstract] [Full Text] [Related]
20. Management of antiretroviral drug therapy in human immunodeficiency virus infection.
Stretcher B
Crit Rev Clin Lab Sci; 1994; 31(2):169-96. PubMed ID: 7917008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
